Throughout this medical market research on the U.S. and European diabetes monitoring, treatment, and drug delivery markets, over 90 companies across 16 countries were analyzed. To conduct this research, our comprehensive methodology was utilized to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. Previously, the U.S. diabetes monitoring, treatment, and

The U.S. and European insulin pump markets include durable pumps and patch pumps, which are further segmented to account for hardware and disposable components. Within both the U.S. and the European insulin pump markets, the largest segment was the durable pump market, which accounted for the majority of the total market value. Durable pumps account for

The European diabetes monitoring, treatment, and drug delivery market, also referred to as the diabetes care market, includes blood glucose meters, blood glucose test strips, lancets, continuous glucose monitoring (CGM), flash glucose monitoring (FGM), insulin, insulin pens, insulin syringes, and insulin pumps. Previously, the European diabetes monitoring, treatment, and drug-delivery market was valued at €6.8 billion.

The U.S. diabetes monitoring, treatment, and drug delivery market, also referred to as the diabetes care market, includes blood glucose meters, blood glucose test strips, lancets, continuous glucose monitoring (CGM), flash glucose monitoring (FGM), insulin, insulin pens, insulin syringes, and insulin pumps. Previously, the U.S. diabetes monitoring, treatment, and drug-delivery market was valued at $15.7